Nothing written yet for this company.
Qurient Co., Ltd. (115180) approved a rights offering to raise about ₩100 billion, Yonhap reported Friday.
| Period | 115180 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | +13.5% | -3.0% | +16.5% |
| 1 month | +5.3% | +4.2% | +1.1% |
| 3 months | -16.6% | -22.5% | +5.9% |
| 6 months | -13.3% | -16.9% | +3.5% |
| Year to date | -23.8% | -12.1% | -11.7% |
| 1 year | +80.4% | +1.0% | +79.4% |
Closed at 29% of the way from its 52-week low (₩11,660) to its 52-week high (₩50,900).
Qurient Co., Ltd. does research and development in science and engineering in South Korea. It is listed on KOSDAQ, was founded in 2008, is based in Gyeonggi, and has revenue of under ten billion won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2008 |
| Korean name | 큐리언트 | Head office | Gyeonggi |
| Symbol | Last Price |
|---|---|
| 003090Daewoong Co., Ltd. | ₩16,860 -2.0% |
| 086450Dong Kook Pharmaceutical Co., Ltd. | ₩21,600 -0.9% |
| 185750Chong Kun Dang Pharmaceutical Corp. | ₩68,000 -0.3% |
| 476830Rznomics, Inc. | ₩28,200 +6.8% |
| 003850Boryung Corporation | ₩9,040 +1.6% |
| 950260Ingenia Therapeutics Inc.(reg.s) | ₩15,580 -1.5% |
| 085660Chabiotech Co., Ltd. | ₩8,090 +2.1% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |